Search Results - "Balsano, Rita"

Pancreatic Ductal Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of Immunotherapy and Spikes of Lights by Balsano, Rita, Zanuso, Valentina, Pirozzi, Angelo, Rimassa, Lorenza, Bozzarelli, Silvia

“…Pancreatic ductal adenocarcinoma (PDAC) is a dismal disease with a poor 5-year overall survival rate (~10%). The revolution of immunotherapy in clinical…”
Get full text

Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management by Gelsomino, Fabio, Balsano, Rita, De Lorenzo, Stefania, Garajová, Ingrid

“…Small bowel adenocarcinoma (SBA) is a rare malignancy, with a rising incidence in recent decades, and accounts for roughly 40% of all cancers of the small…”
Get full text

Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC by Digiacomo, Graziana, Volta, Francesco, Garajova, Ingrid, Balsano, Rita, Cavazzoni, Andrea

“…Pancreatic Ductal Adenocarcinoma (PDAC) is one of the deadliest solid tumors and is estimated to become a leading cause of cancer-related death in coming…”
Get full text

Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer by Comandatore, Annalisa, Immordino, Benoit, Balsano, Rita, Capula, Mjriam, Garajovà, Ingrid, Ciccolini, Joseph, Giovannetti, Elisa, Morelli, Luca

“…In recent years, a growing number of studies have evaluated the role of exosomes in pancreatic ductal adenocarcinoma cancer (PDAC) demonstrating their…”
Get full text

The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review by Schipilliti, Francesca Matilde, Garajová, Ingrid, Rovesti, Giulia, Balsano, Rita, Piacentini, Federico, Dominici, Massimo, Gelsomino, Fabio

“…Hepatocellular carcinoma (HCC) is the main type of liver cancer. In the majority of cases, HCC is diagnosed at the advanced stage, leading to poor prognosis…”
Get full text

Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics by Balsano, Rita, Kruize, Zita, Lunardi, Martina, Comandatore, Annalisa, Barone, Mara, Cavazzoni, Andrea, Re Cecconi, Andrea David, Morelli, Luca, Wilmink, Hanneke, Tiseo, Marcello, Garajovà, Ingrid, van Zuylen, Lia, Giovannetti, Elisa, Piccirillo, Rosanna

“…Cachexia is a metabolic syndrome consisting of massive loss of muscle mass and function that has a severe impact on the quality of life and survival of cancer…”
Get full text

It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer by Garajová, Ingrid, Cavazzoni, Andrea, Verze, Michela, Minari, Roberta, Pedrazzi, Giuseppe, Balsano, Rita, Gelsomino, Fabio, Valle, Raffaele Dalla, Digiacomo, Graziana, Giovannetti, Elisa, Leonardi, Francesco

“…Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with rising incidence and poor prognosis. The lack of reliable prognostic…”
Get full text

The implication of liquid biopsies to predict chemoresistance in pancreatic cancer by Pietri, Elisabetta, Balsano, Rita, Coriano, Matilde, Gelsomino, Fabio, Leonardi, Francesco, Bui, Simona, Gnetti, Letizia, Valle, Raffaele Dalla, Garajová, Ingrid

“…Pancreatic cancer is one of the most aggressive diseases among solid tumors. Most patients are diagnosed with advanced or metastatic disease and are…”
Get full text

State of the Art for Metastatic Pancreatic Cancer Treatment: Where Are We Now? by Balsano, Rita, Tommasi, Chiara, Garajova, Ingrid

“…The prognosis of metastatic pancreatic cancer remains poor despite the recent progress on modern chemotherapeutic regimens, such as FOLFIRINOX, gemcitabine and…”
Get full text

SAT-523 Intrahepatic cholangiocarcinoma: characteristics and outcomes of patients with or without underlying liver disease by Tesini, Giulia, Zanuso, Valentina, Pirozzi, Angelo, Valenzi, Elena, Balsano, Rita, Pressiani, Tiziana, Bozzarelli, Silvia, Rimassa, Lorenza

Get full text

Olaparib as a single agent treatment in pre-treated metastatic pancreatic cancer patient harboring BRCA2 mutation: What could we expect? by Garajová, Ingrid, Balsano, Rita, Gelsomino, Fabio, Leonardi, Francesco

“…Background: Despite ongoing developments, pancreatic cancer remains one of the most difficult tumors to treat. Even the most effective chemotherapy regimens,…”
Get full text

THU-474-YI Immunotherapy in cholangiocarcinoma: understanding the immune landscape reveals treatment response by Balsano, Rita, Pressiani, Tiziana, Milardi, Giulia, Bozzarelli, Silvia, Zanuso, Valentina, Pirozzi, Angelo, Tesini, Giulia, Lleo, Ana, Rimassa, Lorenza

Get full text

The role of the microbiome in drug resistance in gastrointestinal cancers by Garajová, Ingrid, Balsano, Rita, Wang, Heling, Leonardi, Francesco, Giovannetti, Elisa, Deng, Dongmei, Peters, Godefridus J.

“…Introduction: The microbiota is recognized for its impact on both human health and disease. The human microbiota is made up of trillions of cells, including…”
Get full text

Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer by Pressiani, Tiziana, Balsano, Rita, Giordano, Laura, Milella, Michele, Bergamo, Francesca, Bozzarelli, Silvia, Noventa, Silvia, Ferrrari, Daris, Scartozzi, Mario, Parra, Hector Soto, Auriemma, Alessandra, Soldà, Caterina, Zaniboni, Alberto, Zecchetto, Camilla, Rizzato, Mario Domenico, Rimassa, Lorenza, Santoro, Armando

“…The prognosis of patients with advanced biliary tract cancer (BTC) is still poor, and new strategies improving patients’ outcome are needed. In our trial we…”
Get full text

Comment on “Implications of Perineural Invasion on Disease Recurrence and Survival After Pancreatectomy for Pancreatic Head Ductal Adenocarcinoma by Crippa et al.” by Garajová, Ingrid, Balsano, Rita, Donati, Valentina, Gnetti, Letizia, Capula, Mjriam, Leonardi, Francesco, Valle, Raffaele Dalla, Ravaioli, Matteo, Gelsomino, Fabio, Giovannetti, Elisa

Get full text

“Depart from evil, and do good”: Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pancreatic cancer by Comandatore, Annalisa, Balsano, Rita, Immordino, Benoit, Arguedas, Davinia, Capula, Mjriam, Baglio, Serena R., Garajovà, Ingrid, Malapelle, Umberto, Morelli, Luca, Giovannetti, Elisa

“…Attempts to achieve early diagnosis are crucial to improve the outcome of patients with pancreatic ductal adenocarcinoma (PDAC). Here we present a critical…”
Get full text

Investigating possible relationships between pancreatic cancer and hypothyroidism by Garajová, Ingrid, Comandatore, Annalisa, Gelsomino, Fabio, De Lorenzo, Stefania, Pedrazzi, Giuseppe, Spallanzani, Andrea, Martinelli, Giulio, Balsano, Rita, Leonardi, Francesco, Palmeri, Matteo, Di Franco, Gregorio, Guadagni, Simone, Furbetta, Niccolo', Giovannetti, Elisa, Morelli, Luca

Get full text

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide population by Rimini, Margherita, Fornaro, Lorenzo, Rizzato, Mario Domenico, Antonuzzo, Lorenzo, Rossari, Federico, Satake, Tomoyuki, Vandeputte, Hanne, Vivaldi, Caterina, Pressiani, Tiziana, Lucchetti, Jessica, Kim, Jin Won, Abidoye, Oluseyi, Rapposelli, Ilario Giovanni, Tamberi, Stefano, Finkelmeier, Fabian, Giordano, Guido, Nichetti, Federico, Chon, Hong Jae, Braconi, Chiara, Pirrone, Chiara, Castet, Florian, Tamburini, Emiliano, Yoo, Changhoon, Parisi, Alessandro, Diana, Anna, Scartozzi, Mario, Prager, Gerald W., Avallone, Antonio, Schirripa, Marta, Kim, Il Hwan, Perkhofer, Lukas, Oneda, Ester, Verrico, Monica, Adeva, Jorge, Chan, Stephen L., Spinelli, Gian Paolo, Personeni, Nicola, Garajova, Ingrid, Rodriquenz, Maria Grazia, Leo, Silvana, Salani, Francesca, De Rosa, Antonio, Lavacchi, Daniele, Foti, Silvia, Ikeda, Masafumi, Dekervel, Jeroen, Niger, Monica, Balsano, Rita, Tonini, Giuseppe, Kang, Minsu, Bekaii-Saab, Tanios, Esposito, Luca, Boccaccino, Alessandra, Himmelsbach, Vera, Landriscina, Matteo, Djaballah, Selma Ahcene, Zanuso, Valentina, Masi, Gianluca, Lonardi, Sara, Rimassa, Lorenza, Casadei-Gardini, Andrea

“…The TOPAZ-1 phase III trial showed a survival benefit with durvalumab plus gemcitabine and cisplatin in patients with advanced biliary tract cancer (BTC). To…”
Get full text

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population by Lo Prinzi, Federica, Salani, Francesca, Rimini, Margherita, Rizzato, Mario Domenico, Antonuzzo, Lorenzo, Camera, Silvia, Satake, Tomoyuki, Vandeputte, Hanne, Vivaldi, Caterina, Pressiani, Tiziana, Lucchetti, Jessica, Kim, Jin Won, Abidoye, Oluseyi, Rapposelli, Ilario Giovanni, Tamberi, Stefano, Finkelmeier, Fabian, Giordano, Guido, Pircher, Chiara, Chon, Hong Jae, Braconi, Chiara, Pastorino, Alessandro, Castet, Florian, Tamburini, Emiliano, Yoo, Changhoon, Parisi, Alessandro, Diana, Anna, Scartozzi, Mario, Prager, Gerald W, Avallone, Antonio, Schirripa, Marta, Kim, Il Hwan, Perkhofer, Lukas, Oneda, Ester, Verrico, Monica, Adeva, Jorge, Chan, Stephen L, Spinelli, Gian Paolo, Personeni, Nicola, Garajova, Ingrid, Rodriquenz, Maria Grazia, Leo, Silvana, Melo Alvim, Cecilia, Roque, Ricardo, Fornaro, Lorenzo, De Rosa, Antonio, Lavacchi, Daniele, Rossari, Federico, Ikeda, Masafumi, Dekervel, Jeroen, Niger, Monica, Balsano, Rita, Tonini, Giuseppe, Kang, Minsu, Bekaii-Saab, Tanios, Viola, Massimo Giuseppe, Silvestro, Lucrezia, Esposito, Luca, Boccaccino, Alessandra, Himmelsbach, Vera, Landriscina, Matteo, Ahcene Djaballah, Selma, Zanuso, Valentina, Masi, Gianluca, Lonardi, Sara, Rimassa, Lorenza, Casadei-Gardini, Andrea

“…In the TOPAZ-1, patients with biliary tract cancers (BTC) and recurrence within 6 months after surgery were excluded, even if this event is frequently observed…”
Get full text

Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma by Zanuso, Valentina, Pirozzi, Angelo, Balsano, Rita, Pressiani, Tiziana, Rimassa, Lorenza

“…Hepatocellular carcinoma (HCC) is one of the most common leading causes of cancer death worldwide. As most patients are diagnosed with advanced disease,…”
Get full text